• 1
    Bustamante J, Rimola A, Ventura PJ, Navasa M, Cirera I, Reggiardo V, et al. Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 1999; 30: 890895.
  • 2
    Hui AY, Chan HL, Leung NW, Hung LC, Chan FK, Sung JJ. Survival and prognostic indicators in patients with hepatitis B virus-related cirrhosis after onset of hepatic decompensation. J Clin Gastroenterol 2002; 34: 569572.
  • 3
    Romero-Gómez M, Boza F, Garcia Valdecasas MS, García E, Aguilar Reina J. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 2001; 96: 27182723.
    Direct Link:
  • 4
    Das A, Dhiman RK, Saraswat VA, Verma M, Naik SR. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531535.
  • 5
    Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. HEPATOLOGY 1998; 28: 4549.
  • 6
    Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. HEPATOLOGY 2004; 39: 739745.
  • 7
    Romero-Gomez M, Grande L, Camacho I. Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. HEPATOLOGY 2004; 39: 939943.
  • 8
    Vergara Gómez M, Flavià Olivella M, Gil Prades M, Dalmau Obrador B, Córdoba Cardona J. Diagnosis and treatment of hepatic encephalopathy in Spain: results of a survey of hepatologists [in Spanish]. Gastroenterol Hepatol 2006; 29: 16.
  • 9
    Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT, et al. Hepatic encephalopahy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congress of Gastroenterology, Vienna, 1998. HEPATOLOGY 2002; 35: 716721.
  • 10
    Mason RJ, Snelgar RS, Foster DH, Heron JR, Jones RE. Abnormalities of chromatic and luminance critical flicker frequency in multiple sclerosis. Invest Ophthalmol Vis Sci 1982; 23: 246252.
  • 11
    Cronin-Golomb A, Corkin S, Rizzo JF, Cohen J, Growdon JH, Banks KS. Visual dysfunction in Alzheimer's disease: relation to normal aging. Ann Neurol 1991; 29: 4152.
  • 12
    Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Haussinger D. Critical flicker frequency for quantification of low-grade hepatic encephalopathy. HEPATOLOGY 2002; 35: 357366.
  • 13
    Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768773.
  • 14
    Romero-Gomez M, Cordoba J, Jover R, del Olmo J, Fernandez A, Flavia M, et al.; Red Nacional de Investigacion en Encefalopatia Hepatica. Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy [in Spanish]. Med Clin (Barc) 2006; 127: 246249.
  • 15
    de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 2000; 33: 846852.
  • 16
    Arroyo V, Gines P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. HEPATOLOGY 1996; 23: 164176.
  • 17
    Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32: 142153.
  • 18
    Curran S, Wattis J. Critical flicker fusion threshold: a potentially useful measure for the early detection of Alzheimer's disease. Hum Psychopharmacol 2000; 15: 103112.
  • 19
    Jover R, Company L, Gutierrez A, Lorente M, Zapater P, Poveda MJ, et al. Clinical significance of extrapyramidal signs in patients with cirrhosis. J Hepatol 2005; 42: 659665.
  • 20
    Hartmann IJC, Groeneweg M, Quero JC, Beijeman SJ, Man RA, Hop WCJ, et al. The prognostic significance of sub-clinical hepatic encephalopathy. Am J Gastroenterol 2000; 95: 20292034.
    Direct Link:
  • 21
    Amodio P, Del Piccolo F, Petteno E, Mapelli D, Angeli P, Iemmolo R, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001; 35: 3745.
  • 22
    Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of sub-clinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986; 3: 7582.
  • 23
    Gilberstadt SJ, Gilberstadt H, Zieve L, Beugel B, Collier RO, McClain CJ. Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980; 140: 519521.
  • 24
    Weissenborn K, Heidenreich S, Ennen J, Ruckert N, Hecker H. Attention deficits in minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 1319.
  • 25
    Weissenborn K, Ennen J, Rückert N, Schomerus H, Dengler R, Manns MP, et al. The PSE-Test: an attempt to standardize neuropsychological assessment of latent portosystemic encephalopathy (PSE). In: RecordC, Al MardiniH, eds. Advances in Hepatic Encephalopathy and Metabolism in Liver Disease. Newcastle-upon-Tyne: Medical Faculty of the University of Newcastle-upon-Tyne, 1997: 489494.
  • 26
    Montagnese S, Amodio P, Morgan MY. Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach. Metab Brain Dis 2004; 19: 281312.